Mary‐Anne Trabaud - Concepedia

Author

Mary‐Anne Trabaud

Also Known As

Florence Morfin, Frederic Laurent, J C Tardy, J. C. Tardy, Jean-Claude Tardy, Laurence Bocket, M A Trabaud, M Trabaud, M-A. Trabaud, M. A. Trabaud

136

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Inserm Hospices Civils de Lyon Université Claude Bernard Lyon 1 Hôpital de la Croix-Rousse Centre National de la Recherche Scientifique

About

Mary‐Anne Trabaud is an author at Inserm specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	1.3K
2	Public Health	3	3	134
3	Natural Sciences	2	2	132
4	Engineering	1	1	12
5	Health Sciences	1	1	61

Mary‐Anne Trabaud

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. Hervé Lerat, Françoise Berby, Mary‐Anne Trabaud, Journal of Clinical Investigation Negative Strand RnaViral DiagnosticsImmunologyPathologyNucleic Acid Amplification Test	1996	270
In Vivo Tropism of Hepatitis C Virus Genomic Sequences in Hematopoietic Cells: Influence of Viral Load, Viral Genotype, and Cell Phenotype Hervé Lerat, Sylvie Rumin, François Habersetzer, Blood	1998	256
Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity Yannick Debing, Christophe Ramière, Kai Dallmeier, Journal of Hepatology Altered Viral FitnessViral HepatitisRibavirin SensitivityAntiviral TherapyHepatitis	2016	133
Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. Véronique Boyer, Claude Des̀granges, Mary‐Anne Trabaud, The Journal of Experimental Medicine Adaptive Immune SystemAntibody-independent FashionImmunologyCd4 T Cell ResponsesImmune System	1991	114
Occult HBV infection may represent a major risk factor of non‐response to antiviral therapy of chronic hepatitis C Saâd Mrani, Isabelle Chemin, K. Ménouar, Journal of Medical Virology	2007	101
Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro Sylvie Rumin, Pascale Berthillon, Eiji Tanaka, Journal of General Virology Viral ReplicationImmunologyPathologyCulture ModelHcv Replication	1999	101
Transactivation of the Hepatitis B Virus Core Promoter by the Nuclear Receptor FXRα Christophe Ramière, Caroline Scholtès, Olivier Diaz, Journal of Virology Viral ReplicationGeneticsImmunologyHepatitis BMolecular Biology	2008	95
Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test Antonin Bal, Bruno Pozzetto, Mary‐Anne Trabaud, Clinical Chemistry	2021	88
Impact of Highly Active Antiretroviral Therapy (HAART) on the Natural History of Hepatitis B Virus (HBV) and HIV Coinfection: Relationship between Prolonged Efficacy of HAART and HBV Surface and Early Antigen Seroconversion Patrick Miailhes, Mary‐Anne Trabaud, Pierre Pradat, Clinical Infectious Diseases	2007	80
Evaluation of the Genotypic Prediction of HIV-1 Coreceptor Use versus a Phenotypic Assay and Correlation with the Virological Response to Maraviroc: the ANRS GenoTropism Study Patrícia Recordon-Pinson, Cathia Soulié, Philippe Flandre, Antimicrobial Agents and Chemotherapy Hiv-1 Coreceptor UseImmunologyWorse VrTranslational MedicineHuman Retrovirus	2010	74

Page 1